Finasteride
Product Images NDC 33261-833

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Finasteride (NDC 33261-833). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aidarex Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Finasteride 5mg Tab For Hetero 1)

Chemical structure of Finasteride showing its molecular configuration with labeled atoms and bonds in a multi-ring steroidal structure.*

FDA Label Image

Figure1 (Finasteride 5mg Tab For Hetero 2)

A line graph comparing the mean change from baseline with two groups: Finasteride and Placebo over four years. The y-axis shows mean change from baseline ± 1 SE, and the x-axis tracks time from baseline to year 4. Two distinct lines represent the groups, with patient counts noted below for each year.*

FDA Label Image

Figure2 (Finasteride 5mg Tab For Hetero 3)

A line graph titled 'Figure 2 Percent of Patients Having Surgery for BPH, Including TURP' comparing the cumulative percent of patients undergoing surgery over 48 months between Finasteride and placebo groups. The x-axis shows observation time in months, and the y-axis shows the percent of patients up to 15%. Lines indicate fewer surgeries in the Finasteride group versus placebo. Below the graph is a table listing cumulative number of events and patient risk counts per year for both groups.*

FDA Label Image

Figure3 (Finasteride 5mg Tab For Hetero 4)

A line graph comparing mean percent change from baseline over four years between placebo and Finasteride groups. The y-axis shows mean percent change ± 1 SE, ranging from -20 to 20. The x-axis marks time points at baseline and years 1 through 4, showing divergence of results between the two groups over time.*

FDA Label Image

Figure4 (Finasteride 5mg Tab For Hetero 5)

A line graph illustrating the percent of participants with an event over a period of up to 5.5 years from randomization, comparing four groups: Placebo, Finasteride, Doxazosin, and a Combination therapy. The y-axis represents the percent with event, and the x-axis represents years from randomization, showing distinct curves for each treatment group.*

FDA Label Image

Image Label (Finasteride 5mg Tab For Hetero 6)

Finasteride 5 mg tablet label from Aidarex Pharmaceuticals LLC. It shows 90 tablets per package. The label indicates the active ingredient as finasteride, film-coated, 5 mg per tablet. It is a generic for Proscar, manufactured by Hetero Labs Limited India, with NDC 33261-0833-90. The label includes dosing instructions and warnings about federal law.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.